| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/07/2004 | EP1377353A1 Cell separation compositions and methods |
| 01/07/2004 | EP1377319A2 Fusion proteins |
| 01/07/2004 | EP1377310A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 01/07/2004 | EP1377305A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/07/2004 | EP1377251A2 A cell therapy method for the treatment of tumors |
| 01/07/2004 | EP1377165A2 Tsg101-gag interaction and use thereof |
| 01/07/2004 | EP1377157A2 Novel pesticidal toxins |
| 01/07/2004 | EP1230354B1 Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |
| 01/07/2004 | EP1034187B1 Growth-promoting proteins and peptides for kidney epithelial cells |
| 01/07/2004 | EP1028741B1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 01/07/2004 | EP0931092B1 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 01/07/2004 | CN1466682A HCV antigen/antibody combination assay |
| 01/07/2004 | CN1466629A Modulation of abscisic acid signal transduction in plants |
| 01/07/2004 | CN1466625A Method of proliferating natural killer cells |
| 01/07/2004 | CN1133747C Process for preparing oligosaccharide resistance inductor by tissue culture of cephalotaxus cells |
| 01/07/2004 | CN1133745C Method for immortalizing cells and immortalized cell |
| 01/07/2004 | CN1133370C Control cell for use in identification of common acute lymphoblast leukemia and preparation process thereof |
| 01/06/2004 | US6673990 Biopesticides |
| 01/06/2004 | US6673987 Strategy for maintaining pregnancy |
| 01/06/2004 | US6673904 Stem cell growth factor-like polypeptides |
| 01/06/2004 | US6673903 Antiproliferative agents |
| 01/06/2004 | US6673899 Protein for use treatment of diabetes |
| 01/06/2004 | US6673895 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 01/06/2004 | US6673768 Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) |
| 01/06/2004 | US6673611 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 01/06/2004 | US6673609 Diagnosing anemia |
| 01/06/2004 | US6673608 Somatic embryogenic regeneration of Acacia mangium |
| 01/06/2004 | US6673607 Cryogenic stabilization of cells; obtain cells, inject with cryogenic agent, activate latent state, store cells |
| 01/06/2004 | US6673606 Therapeutic uses for mesenchymal stromal cells |
| 01/06/2004 | US6673605 Established cell line of microglia |
| 01/06/2004 | US6673604 Muscle cells and their use in cardiac repair |
| 01/06/2004 | US6673603 Cell paste for tissue regeneration, comprising: (a) one or more cells that naturally secretes one or more biologically active molecules admixed with (b) an extracellular matrix or matrix material |
| 01/06/2004 | US6673600 Transgenic C. elegans as a model organism for investigations on Alzheimer's disease |
| 01/06/2004 | US6673590 Multiply-substituted protease variants with altered net charge for use in detergents |
| 01/06/2004 | US6673583 Recombinantly producing levodione reductase |
| 01/06/2004 | US6673575 Use of cultured, recombinant eukaryotic cells in the production of glycoproteins for pharmaceutical use especially given the control in degree of glycosylation afforded by the procedure |
| 01/06/2004 | US6673573 Expression of immunoglobulin-cytokine fusion proteins in malignant B cells |
| 01/06/2004 | US6673571 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 01/06/2004 | US6673564 Detecting modulators of polypeptide activity in cell; obtain cell, incubate with modulator, monitor cellular activity and compare to control |
| 01/06/2004 | US6673351 Immunotherapeutic agent comprising purified protein extract derived from killed cells of amastigotes and leishmania |
| 01/06/2004 | US6673350 Argleuleugluphetyrleualamet nonapeptide and t lymphocyte cell sample from melanoma subject; reacts with major histocompatibility complex; cancer, autoimmune disease, and infection diagnosis |
| 01/06/2004 | US6673348 Heat shock protein-based vaccines and immunotherapies |
| 01/06/2004 | US6673344 Antibodies to human CKβ-10/MCP-4 |
| 01/06/2004 | US6673339 Prosthetic kidney and its use for treating kidney disease |
| 01/06/2004 | CA2135083C Antibodies to p-selectin and their uses |
| 01/06/2004 | CA2134094C Production of recombinant human lactoferrin |
| 01/06/2004 | CA2128208C Novel seven transmembrane receptors |
| 01/06/2004 | CA2086681C Growth promoting agent derived from milk |
| 01/02/2004 | EP1375668A1 Vegetative growth-specific promoter and genetically modified plants obtained thereby |
| 01/02/2004 | EP1375667A1 Rice-origin high expression polypeptide chain elongation factor promoter and method of using the same |
| 01/02/2004 | EP1375666A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof |
| 01/02/2004 | EP1375662A1 A novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 01/02/2004 | EP1375647A1 Artificial dermis and production method therefor |
| 01/02/2004 | EP1375646A1 Genetically engineered keratinocytes expressing at least one growth factor and/or activated EGF receptor, skin equivalent comprising said keratinocytes and toxicity assay using said keratinocytes |
| 01/02/2004 | EP1375645A1 Yeast cells as dietary supplements for enhancing the immune system |
| 01/02/2004 | EP1375520A1 Apoptosis induced by monoclonal antibody anti-Her2 |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1374889A1 Method of inducing angiogenesis by micro-organs |
| 01/02/2004 | EP1373896A2 Cell-based detection and differentiation of disease states |
| 01/02/2004 | EP1373888A2 Method for screening for progesterone receptor isoform-specific ligands |
| 01/02/2004 | EP1373559A2 Identification of neural defects associated with the nucleosomal assembly protein 1l2 gene |
| 01/02/2004 | EP1373554A2 Modulators of bruton's tyronsine kinase, their identification and use |
| 01/02/2004 | EP1373547A1 Control of glycoforms in igg |
| 01/02/2004 | EP1373536A2 Lentiviral packaging constructs |
| 01/02/2004 | EP1373535A2 Improved gene expression |
| 01/02/2004 | EP1373528A1 Novel expression vectors |
| 01/02/2004 | EP1373525A1 Gene-targeted animal model of apolipoprotein e4 domain interaction and uses thereof |
| 01/02/2004 | EP1373524A2 Cytomegalovirus intron a fragments |
| 01/02/2004 | EP1373523A1 Genetic modification of plants for enhanced resistance and decreased uptake of heavy metals |
| 01/02/2004 | EP1373522A2 D-carbamoylase from arthrobacter crystallopoietes dsm 20117 |
| 01/02/2004 | EP1373519A2 New elongase gene and production of delta-9-polyunsaturated fatty acids |
| 01/02/2004 | EP1373518A2 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preparation of a medicament for the treatment of metabolic disorders |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373516A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 01/02/2004 | EP1373511A2 Genes and proteins, and their uses |
| 01/02/2004 | EP1373510A2 Mutant allergens |
| 01/02/2004 | EP1373508A2 Human cytokine receptor |
| 01/02/2004 | EP1373505A2 Tri-hybrid melanoma antigen |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373503A2 Neurotrophic factors |
| 01/02/2004 | EP1373502A2 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 01/02/2004 | EP1373493A1 Coagulation factor vii derivatives |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373485A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby |
| 01/02/2004 | EP1373481A1 Methods of screening for introduction of dna into a target cell |
| 01/02/2004 | EP1373477A2 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 01/02/2004 | EP1373476A2 Cytochrome p450s and uses thereof |
| 01/02/2004 | EP1373475A2 Immunotherapy based on dendritic cells |
| 01/02/2004 | EP1373474A2 A method for producing a population of homozygous stem cells having a pre-selected immunophenotype and/or genotype |
| 01/02/2004 | EP1373473A1 Gene targeting methods and vectors |
| 01/02/2004 | EP1373472A1 Methods and gel compositions for encapsulating living cells and organic molecules |
| 01/02/2004 | EP1373471A2 Defined culture medium |
| 01/02/2004 | EP1373470A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/02/2004 | EP1373320A2 Method for preparing and selecting antibodies |
| 01/02/2004 | EP1373318A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373312A1 Shellfish protein |